PipelineReview.com (press release) ... SciClone a license and the exclusive rights in China, Hong Kong and Macau to promote, market, distribute and sell Neucardin™, a novel, first-in-class therapeutic drug for the treatment of patients with intermediate to advanced chronic heart ... 更多 »
Daily Beast Complaining that generic drugs from abroad are nothing but cheap fakes has long been a staple of free-trade opponents, and of course, pharmaceutical manufacturers trying to protect their products from foreign competition. While it's long been clear ... 更多 »
The Sanatoga Post Don Clancy is an R&D Investigator for the “Process Understanding and Control” team in Pharmaceutical Development for GlaxoSmithKline in Upper Merion, Pennsylvania. For the past four of his eight years ... He previously served as the Montgomery County ... 更多 »
Wall Street Journal (press release) The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high ... and more »
Fort Mills Times Oxea is a global manufacturer of oxo intermediates and oxo derivatives, such as alcohols, polyols, carboxylic acids, specialty esters, and amines. These products are used among others for the production of high-quality coatings, lubricants, cosmetics ... and more »
